Science Journals In Immunotherapy|OMICS International|Translational Medicine

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Science Journals In Immunotherapy

Science Journals are multidimensional Open Access gateways for the exploration of scientific discoveries and new research in the medical and other sciences. These journals are periodical publications intended to communicate with the scientific community to further the progress of mankind. Science Journals represent the collaborative efforts of many scientists and scholars from various disciplines. Science literatures have evolved from time to time in terms of specialization and target audience. Reports of new research findings are important to fuel novel assumptions and discoveries that can only be in existence through the publication of scientific Science journals. Although some Science Journals are multidisciplinary, most journals are highly specialized and they publish articles related to specific scientific fields. Allergic rhino-conjunctivitis and asthma are caused by sensitization to one or more allergens in susceptible individuals. Specific immunotherapy (SIT) is indicated in IgE-dependent allergy and represents a potentially curative treatment approach in allergic diseases. The traditional subcutaneous immunotherapy (SCIT) has been largely demonstrated to be effective in inducing tolerance in individuals with allergic respiratory diseases. However, the risk of severe adverse events (SAE), partly related to technical or human errors, is not of little importance. The practice of administering sublingual immunotherapy (SLIT) for respiratory allergy, introduced for the first time in the mid-eighties is gaining increasing diffusion worldwide based on the proved clinical efficacy and safety both in adult and in pediatric individuals with allergic rhino-conjunctivitis and/or asthma sensitized to seasonal or perennial allergens. An important and intriguing aspect of immunotherapy, which is missing in conventional pharmacological treatments, is the long-lasting beneficial effect after discontinuation. Several SLIT studies in adults and children show that the beneficial effects are maintained for up to 6 years after discontinuation of SLIT. (Rita Arrigo and Nicola Scichilone, The Effect of Immunotherapy in Allergic Respiratory Diseases: Reappraisal of Current Knowledge)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on August, 2021